{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T01:53:05Z","timestamp":1773193985059,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81274099"],"award-info":[{"award-number":["81274099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ejps.2016.12.033","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T14:55:16Z","timestamp":1483628116000},"page":"155-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["HII mesophase as a drug delivery system for topical application of methyl salicylate"],"prefix":"10.1016","volume":"100","author":[{"given":"Xin","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-jing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang-ying","family":"Gui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2016.12.033_bb0005","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.colsurfb.2016.05.091","article-title":"Impact of preparation method and variables on the internal structure, morphology, and presence of liposomes in phytantriol-Pluronic\u00ae F127 cubosomes","volume":"145","author":"Akhlaghi","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ejps.2016.12.033_bb0010","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.colsurfb.2005.03.011","article-title":"Transitions induced by solubilized fat into reverse hexagonal mesophases","volume":"43","author":"Amar-Yuli","year":"2005","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ejps.2016.12.033_bb0015","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1021\/jp711421k","article-title":"Low viscosity reversed hexagonal mesophases induced by hydrophilic additives","volume":"112","author":"Amar-Yuli","year":"2008","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejps.2016.12.033_bb0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jcis.2011.05.047","article-title":"The role of glycerol and phosphatidylcholine in solubilizing and enhancing insulin stability in reverse hexagonal mesophases","volume":"364","author":"Amar-Yuli","year":"2011","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2016.12.033_bb0025","doi-asserted-by":"crossref","first-page":"9562","DOI":"10.1021\/la0350812","article-title":"Phase behaviour of the phytantriol\/water system","volume":"19","author":"Barauskas","year":"2003","journal-title":"Langmuir"},{"key":"10.1016\/j.ejps.2016.12.033_bb0030","series-title":"Pharmacopoeia of the People's Republic of China","author":"Chinese Pharmacopoeia Commission","year":"2015"},{"key":"10.1016\/j.ejps.2016.12.033_bb0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1467-2494.2005.00264.x","article-title":"Elastic vesicles as topical\/transdermal drug delivery systems","volume":"27","author":"Choi","year":"2005","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.ejps.2016.12.033_bb0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.colsurfb.2010.01.013","article-title":"HII mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac","volume":"77","author":"Cohen-Avrahami","year":"2010","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ejps.2016.12.033_bb0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10787-016-0270-7","article-title":"Evaluation of anti-inflammatory, analgesic activities, and side effects of some pyrazole derivatives","volume":"24","author":"Domiati","year":"2016","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejps.2016.12.033_bb0050","doi-asserted-by":"crossref","first-page":"9512","DOI":"10.1021\/la061706v","article-title":"Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure","volume":"22","author":"Dong","year":"2006","journal-title":"Langmuir"},{"key":"10.1016\/j.ejps.2016.12.033_bb0055","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1359-0294(00)00020-0","article-title":"Surfactant self-assembly objects as novel drug delivery vehicles","volume":"4","author":"Drummond","year":"1999","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2016.12.033_bb0060","first-page":"19","article-title":"Panthenol, phytantriol, vitamin E and vitamin A in cosmetics","author":"Erlemann","year":"1994","journal-title":"Kozment"},{"key":"10.1016\/j.ejps.2016.12.033_bb0065","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijpharm.2015.12.008","article-title":"Shear rheology and in-vitro release kinetic study of apigenin from lyotropic liquid crystal","volume":"497","author":"Fana","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.033_bb0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0142-9612(96)00087-7","article-title":"An investigation of the parameters influencing the bioadhesive properties of Myverol 18-99\/water gels","volume":"18","author":"Geraghty","year":"1997","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2016.12.033_bb0075","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/08990228909144676","article-title":"Methyl salicylate as a cutaneous stimulus: a psychophysical analysis","volume":"6","author":"Green","year":"1989","journal-title":"Somatosens. Mot. Res."},{"key":"10.1016\/j.ejps.2016.12.033_bb0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.clinthera.2010.01.016","article-title":"Efficacy and safety profile of a topical methyl salicylate and menthol patch in adult patients with mild to moderate muscle strain: a randomized, double-blind, parallel-group, placebo-controlled, multicenter study","volume":"32","author":"Higashi","year":"2010","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejps.2016.12.033_bb0085","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijpharm.2008.08.022","article-title":"Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs","volume":"365","author":"Lee","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.033_bb0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijpharm.2008.09.048","article-title":"Molecular interactions in reverse hexagonal mesophase in the presence of Cyclosporin A","volume":"367","author":"Libster","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.033_bb0095","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1021\/jp810309d","article-title":"Concentration and temperature-induced effects of incorporated desmopressin on the properties of reverse hexagonal mesophase","volume":"113","author":"Libster","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejps.2016.12.033_bb0100","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jcis.2011.01.047","article-title":"Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications","volume":"356","author":"Libster","year":"2011","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2016.12.033_bb0105","first-page":"146","article-title":"Liquid crystalline phases of monoolein and water for topical delivery of cyclosporin A: characterization and study of in vitro and in vivo delivery","volume":"63","author":"Lopes","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2016.12.033_bb0110","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejps.2007.07.006","article-title":"Enhancement of skin penetration of vitamin K using monoolein-based liquid crystalline systems","volume":"32","author":"Lopes","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2016.12.033_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcis.2012.10.014","article-title":"Advances in drug delivery and medical imaging using colloidal lyotropic liquid crystalline dispersions","volume":"393","author":"Mulet","year":"2013","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2016.12.033_bb0120","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1021\/la950602+","article-title":"Physical-chemical properties of the n-octayl \u03b2-d-glucoside\/water system. A phase diagram, self-diffusion NMR, and SAXS study","volume":"12","author":"Nilsson","year":"1996","journal-title":"Langmuir"},{"key":"10.1016\/j.ejps.2016.12.033_bb0125","first-page":"1","article-title":"Phytantriol based liquid crystal provide sustained release of anticancer drug as a novel embolic agent","author":"Qin","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2016.12.033_bb0130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0169-409X(01)00108-9","article-title":"Cubic phase as drug delivery systems","volume":"47","author":"Shah","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2016.12.033_bb0135","first-page":"451","article-title":"Simultaneous transport and metabolism of methyl salicylate in pig skin","volume":"21","author":"Shen","year":"2001","journal-title":"Chin. Hosp. Pharm. J."},{"key":"10.1016\/j.ejps.2016.12.033_bb0140","author":"U.S. Food & Drug Administration"},{"key":"10.1016\/j.ejps.2016.12.033_bb0145","series-title":"Experimental Methodology of Pharmacology","author":"Wei","year":"2010"},{"key":"10.1016\/j.ejps.2016.12.033_bb0150","first-page":"837","article-title":"Preparation of cubic liquid crystal as a drug delivery system for methyl salicylate","volume":"24","author":"Wu","year":"2015","journal-title":"Chin. New Drugs J."},{"key":"10.1016\/j.ejps.2016.12.033_bb0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5650\/jos.60.31","article-title":"Preparation and evaluation of liquid crystal formulations with skin-permeation-enhancing abilities for entrapped drug","volume":"60","author":"Yamada","year":"2011","journal-title":"J. Oleo. Sci."},{"key":"10.1016\/j.ejps.2016.12.033_bb0160","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jcis.2006.10.045","article-title":"Formation of intermediate micellar phase between hexagonal and discontinuous cubic liquid crystals in brine\/N-acylamino acid surfactant\/N-acylamino acid oil system","volume":"312","author":"Yamashita","year":"2007","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2016.12.033_bb0165","series-title":"Guidelines for Clinical Research on Chinese New Herbal Medicines (Trial Implementation)","author":"Zheng","year":"2002"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716305735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716305735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T04:56:38Z","timestamp":1536123398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098716305735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":33,"alternative-id":["S0928098716305735"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2016.12.033","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HII mesophase as a drug delivery system for topical application of methyl salicylate","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2016.12.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}